Detroit, Michigan 48201

  • Hematopoietic Cell Transplant


This is a multi-center, Phase II, cross-sectional study comparing quality of life (QOL) as assessed by patient-reported outcomes (PROs) in older (≥65 years) adults vs younger (55-64 years) undergoing allogeneic hematopoietic cell transplantation (HCT) for myelodysplastic syndromes (MDS).

Study summary:

Transplant recipients who have met the inclusion and exclusion criteria and from participating study sites will be asked to complete an online consent and survey for the study. This survey is the patient-reported outcomes survey and will be used to assess quality of life. The survey results will then be compared by age group and by time post transplant, between 6 months and a year post transplant, 1 year to 3 years post transplant, and 3 years or more post transplant.


Inclusion Criteria: In order to be eligible to participate on this study, an individual must meet all of the following criteria: 1. Underwent an allogeneic HCT for MDS on the 10-CMSMDS-1 protocol 2. Prior consent to research and future contact by the CIBMTR 3. Ability to provide RCI BMT protocol 17-ePRO signed and dated informed consent form (ICF) 4. Age ≥55 years at time of transplant 5. Fluent in English or Spanish 6. Greater than 6 months post-HCT Exclusion Criteria: An individual who meets any of the following criteria will be excluded from participation on this study. 1. No access to an internet browser or email account 2. Within 6 months of first HCT for MDS on the 10-CMSMDS-1 protocol



Primary Contact:

Principal Investigator
Bronwen E Shaw, MD, PhD
Center for International Blood and Marrow Transplant Research (CIBMTR)/Medical College of Wisconsin

Backup Contact:


Location Contact:

Detroit, Michigan 48201
United States

There is no listed contact information for this specific location.

Site Status: N/A

Data Source:

Date Processed: July 27, 2021

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.

Click to view Full Listing

This study is not currently recruiting Study Participants on The form below is not enabled.